A Year In Review
The Beacon Checkpoint 2024 Landscape Review provides an in-depth analysis of the checkpoint therapy landscape, including the latest surge in preclinical activity and the evolving clinical and regulatory trends shaping the field. With over 200 new preclinical drugs identified in 2024, the landscape is expanding rapidly, driven by novel mechanisms like next-generation checkpoint targets and bispecific antibodies.
Full Version Now Available
Download this critical review to gain an in-depth analysis of the evolving checkpoint therapy landscape. With growing competition and strategic investment shifts, stay at the forefront of information in the space with Beacon’s 2024 Landscape Review.
Report Contents
The Drug Landscape
A deep dive into the ICM’s entering the clinic, drug approvals, and discontinuations.
The Trial Landscape
Analysis of checkpoint trials including phase distribution, and status updates.
The Commercial Market
A review of the checkpoint deals in 2024, analyzing financing value and investment levels.
The Future of Checkpoint
A glance into the future of the checkpoint landscape and the direction of research moving forward.
Regulatory Announcements
A breakdown of all the regulatory updates in the checkpoint space in 2024.
You May Also Be Interested In...
Checkpoint: 2024 Landscape Review
Bispecific: 2024 Landscape Review
ADC: 2024 Landscape Review
Strategic Insights for Biopharma Innovation Report
H1 2024 Bispecific Landscape Review
H1 2024 Checkpoint Landscape Review
Find Out More
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts. Beacon is here to support you in making these decisions with confidence through our encompassing database solution.
With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.
Any questions? Get in touch
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
